Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
TM · NYSE · United States · Motor Vehicles & Passenger Car Bodies
In shortTOYOTA MOTOR CORP/ is profitable, generates cash and carries moderate debt, with revenue growing (+6.5% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 10.0% | 50/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 9.9% | 60/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 13.6% | 68/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 4.8% | 32/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.26× | 38/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 1.08× | 51/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 4.23× | 0/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 2.90× | 13/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.79 | 43/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 7.7% | 51/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 0.78× | 59/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 12.3% | 66/100 |
| Operating margin volatility | 1.8% | 93/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 15.3% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | 20.6% | 100/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
JPY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 27,214,594 | 31,379,507 | 37,154,298 | 45,095,325 | 48,036,704 |
| Research & development | 1,084,721 | 1,091,675 | 1,224,564 | 1,238,271 | 1,377,018 |
| Selling, general & admin | 2,634,625 | 2,975,977 | 3,587,990 | 4,015,383 | 4,782,452 |
| Operating income | 2,197,748 | 2,995,697 | 2,725,025 | 5,352,934 | 4,795,586 |
| Interest expense | 471,505 | 410,197 | 651,979 | 1,213,021 | 1,654,702 |
| Pre-tax income | 2,932,354 | 3,990,532 | 3,668,733 | 6,965,085 | 6,414,590 |
| Income tax | 649,976 | 1,115,918 | 1,175,765 | 1,893,665 | 1,624,835 |
| Net income | 2,245,261 | 2,850,110 | 2,451,318 | 4,944,933 | 4,765,086 |
| Diluted EPS | ¥158.93 | ¥205.23 | ¥179.47 | ¥365.94 | ¥359.56 |
| Diluted shares (millions) | 13,976 | 13,887 | 13,658 | 13,513 | 13,252 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.79 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Mar 31, 2026 · Data updated Jun 18, 2025